Pharsight

Wyeth Pharms patents expiration

1. Duavee patents expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents protects the active chemical substance. Only drug patent owner can launch products that use this active substance.
US7138392 WYETH PHARMS 2-phenyl-1-[4-(2-aminoethoxy)-benzyl]-indoles as estrogenic agents
Apr, 2017

(7 years ago)

US5998402 WYETH PHARMS 2-phenyl-1-[4-(2-aminoethoxy)-benzyl]-indoles as estrogenic agents
Apr, 2019

(5 years ago)

US7683051 WYETH PHARMS Crystalline polymorph of bazedoxifene acetate
Mar, 2027

(2 years from now)

These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US8815934 WYETH PHARMS 2-Phenyl-1-[4-(2-Aminoethoxy)-Benzyl]-Indole and estrogen formulations
May, 2019

(5 years ago)

US6479535 WYETH PHARMS 2-phenyl-1-[4-(2-aminoethoxy)-benzyl]-indole and estrogen formulations
May, 2024

(a month ago)

Drug Exclusivity Drug Exclusivity Expiration
New Chemical Entity Exclusivity(NCE) Oct 13, 2018
New Product(NP) Oct 03, 2016

Drugs and Companies using BAZEDOXIFENE ACETATE; ESTROGENS, CONJUGATED ingredient

NCE-1 date: 13 October, 2017

Market Authorisation Date: 03 October, 2013

Treatment: Treatment of moderate to severe vasomotor symptoms associated with menopause; Prevention of postmenopausal osteoporosis

Dosage: TABLET;ORAL

More Information on Dosage

DUAVEE family patents

Family Patents

2. Premphase 14/14 patents expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US5547948 WYETH PHARMS Controlled release of steroids from sugar coatings
Jan, 2015

(9 years ago)

Drugs and Companies using ESTROGENS, CONJUGATED; MEDROXYPROGESTERONE ACETATE ingredient

Market Authorisation Date: 17 November, 1995

Treatment: NA

Dosage: TABLET;ORAL-28

More Information on Dosage

PREMPHASE 14/14 family patents

Family Patents

Stay ahead of others in designing the generic launch strategy of these 5 blockbuster drugs expiring in next 5 years.

Get the exclusive patent insights now. Don't be the last to know.

3. Prempro patents expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US5547948 WYETH PHARMS Controlled release of steroids from sugar coatings
Jan, 2015

(9 years ago)

Drugs and Companies using ESTROGENS, CONJUGATED; MEDROXYPROGESTERONE ACETATE ingredient

Market Authorisation Date: 17 November, 1995

Treatment: NA

Dosage: TABLET;ORAL-28

More Information on Dosage

PREMPRO family patents

Family Patents

4. Protonix patents expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US5997903 WYETH PHARMS Oral-administration forms of a medicament containing pantoprazol
Dec, 2016

(7 years ago)

US5997903

(Pediatric)

WYETH PHARMS Oral-administration forms of a medicament containing pantoprazol
Jun, 2017

(7 years ago)

US7553498 WYETH PHARMS Pantoprazole multiparticulate formulations
Sep, 2024

(3 months from now)

US7838027 WYETH PHARMS Pantoprazole multiparticulate formulations
Sep, 2024

(3 months from now)

US7550153 WYETH PHARMS Pantoprazole multiparticulate formulations
Sep, 2024

(3 months from now)

US7838027

(Pediatric)

WYETH PHARMS Pantoprazole multiparticulate formulations
Mar, 2025

(9 months from now)

US7550153

(Pediatric)

WYETH PHARMS Pantoprazole multiparticulate formulations
Mar, 2025

(9 months from now)

US7553498

(Pediatric)

WYETH PHARMS Pantoprazole multiparticulate formulations
Mar, 2025

(9 months from now)

US7544370 WYETH PHARMS Pantoprazole multiparticulate formulations
Jun, 2026

(1 year, 11 months from now)

US7544370

(Pediatric)

WYETH PHARMS Pantoprazole multiparticulate formulations
Dec, 2026

(2 years from now)

Drug Exclusivity Drug Exclusivity Expiration
M(M-54) Nov 12, 2012
New Indication(I-614) Nov 12, 2012
Pediatric Exclusivity(PED) May 12, 2013

Drugs and Companies using PANTOPRAZOLE SODIUM ingredient

Market Authorisation Date: 12 June, 2001

Treatment: Erosive esophagitis, hypersecretory conditions including zollinger-ellison syndrome, maintenance of healing of erosive esophagitis and reduction of symptoms in patients with gerd

Dosage: TABLET, DELAYED RELEASE;ORAL; FOR SUSPENSION, DELAYED RELEASE;ORAL

How can I launch a generic of PROTONIX before it's drug patent expiration?
More Information on Dosage

PROTONIX family patents

Family Patents

5. Protonix Iv patents expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US6780881 WYETH PHARMS Freeze-dried pantoprazole preparation and pantoprazole injection
Nov, 2021

(2 years ago)

US8754108 WYETH PHARMS Freeze-dried pantoprazole preparation and pantoprazole injection
Nov, 2021

(2 years ago)

US7351723 WYETH PHARMS Freeze-dried pantoprazole preparation and pantoprazole injection
Nov, 2021

(2 years ago)

US6780881

(Pediatric)

WYETH PHARMS Freeze-dried pantoprazole preparation and pantoprazole injection
May, 2022

(2 years ago)

US8754108

(Pediatric)

WYETH PHARMS Freeze-dried pantoprazole preparation and pantoprazole injection
May, 2022

(2 years ago)

US7351723

(Pediatric)

WYETH PHARMS Freeze-dried pantoprazole preparation and pantoprazole injection
May, 2022

(2 years ago)

Drugs and Companies using PANTOPRAZOLE SODIUM ingredient

Market Authorisation Date: 22 March, 2001

Treatment: NA

Dosage: INJECTABLE;INTRAVENOUS

How can I launch a generic of PROTONIX IV before it's drug patent expiration?
More Information on Dosage

PROTONIX IV family patents

Family Patents

6. Zosyn patents expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US8133883 WYETH PHARMS Compositions containing piperacillin and tazobactam useful for injection
Apr, 2023

(1 year, 2 months ago)

US7915229 WYETH PHARMS Compositions containing piperacillin and tazobactam useful for injection
Apr, 2023

(1 year, 2 months ago)

US6900184 WYETH PHARMS Compositions containing pipercillin and tazobactam useful for injection
Apr, 2023

(1 year, 2 months ago)

Drugs and Companies using PIPERACILLIN SODIUM; TAZOBACTAM SODIUM ingredient

Market Authorisation Date: 22 October, 1993

Treatment: Method of treating bacterial infections

Dosage: INJECTABLE;INJECTION

How can I launch a generic of ZOSYN before it's drug patent expiration?
More Information on Dosage

ZOSYN family patents

Family Patents